SYMPTOMATIC PARKINSON DISEASE
Clinical trials for SYMPTOMATIC PARKINSON DISEASE explained in plain language.
Never miss a new study
Get alerted when new SYMPTOMATIC PARKINSON DISEASE trials appear
Sign up with your email to follow new studies for SYMPTOMATIC PARKINSON DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Could a common blood pressure pill slow Parkinson's?
Disease control OngoingThis study looks at whether terazosin, a drug usually used for high blood pressure, can slow the progression of Parkinson's disease. Researchers are following 15 people with early signs of Parkinson's or a related sleep disorder. They use special scans and symptom checks over 3 y…
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Disease control
Last updated May 15, 2026 11:54 UTC
-
Heart drug may reveal Parkinson's clues in brain scans
Knowledge-focused OngoingThis study looks at how carvedilol, a medication usually used for heart conditions, affects brain scans over three years in 15 people who have early signs that may lead to Parkinson's disease. Participants have REM sleep behavior disorder and other risk factors. The goal is to be…
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated May 17, 2026 07:36 UTC
-
Could a common heart pill protect against Parkinson's?
Knowledge-focused OngoingThis study looks at whether carvedilol, a drug used for heart failure, can reverse early heart abnormalities seen in people with REM sleep behavior disorder (RBD) who are at high risk for Parkinson's disease. Fifteen participants will take carvedilol and have heart and brain scan…
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Michele Tagliati, MD • Aim: Knowledge-focused
Last updated May 11, 2026 20:49 UTC
-
Could a common blood pressure pill reveal Parkinson's secrets?
Knowledge-focused OngoingThis study looks at whether terazosin, a drug used for high blood pressure, can change how the heart's nerves work in people who may be in the early stages of Parkinson's disease. Researchers are studying 15 adults aged 50-85 with REM sleep behavior disorder, a known risk factor …
Matched conditions: SYMPTOMATIC PARKINSON DISEASE
Phase: PHASE2 • Sponsor: Cedars-Sinai Medical Center • Aim: Knowledge-focused
Last updated May 11, 2026 20:37 UTC